The FDA recently granted marketing authorization for the TriVerity Test System — a new molecular diagnostic test developed by Inflammatix. This first-of-its-kind test provides a comprehensive ...
Recommendations are presented for the diagnostic evaluation of patients with Alzheimer disease (AD) or AD and related dementias (ADRD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback